Pancreatic cancer trials recruiting in California

All Pancreatic cancer trials nationally

Cities in California

Recruiting trials in California

• 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
  NCT06298916 · Phase: Phase 1, Phase 2 · Ages: 15 Years and older · Sex: All (male and female) · California: Duarte, Orange, Stanford
• A Beta-only IL-2 ImmunoTherapY Study
  NCT05086692 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego, San Francisco, Santa Monica
• A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
  NCT06428409 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
  NCT07049055 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: El Segundo
• A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
  NCT07224750 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
  NCT07458347 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
  NCT05932862 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Fountain Valley
• A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
  NCT07157033 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Irvine
• A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
  NCT07020221 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
  NCT07644559 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
  NCT03394365 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · California: Duarte, La Jolla, Loma Linda, Los Angeles
• A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
  NCT06906562 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Fresno, Los Angeles, San Diego, San Francisco
• A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
  NCT06244771 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, Orange, San Francisco
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
  NCT04657068 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Santa Barbara, Santa Rosa
• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
  NCT05365581 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Orange, Santa Monica
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
  NCT07488676 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
  NCT04895709 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Clovis, Los Angeles, Newport Beach
• A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
  NCT07492680 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
  NCT06778863 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Sacramento, San Francisco
• A Study of DM002 in Patients With Advanced Solid Tumors
  NCT06751329 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
  NCT06983743 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · California: Santa Rosa
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
  NCT06172478 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
  NCT07277413 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Santa Rosa
• A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
  NCT07229313 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Santa Monica
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
  NCT06465069 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, La Jolla, Los Angeles
• A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
  NCT06400472 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla
• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
  NCT07213791 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Newport Beach, Stanford
• A Study of MGC026 in Participants With Advanced Solid Tumors
  NCT06242470 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study of MGC028 in Participants With Advanced Solid Tumors
  NCT06723236 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
  NCT07066657 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, San Francisco
• A Study of MT-4561 in Patients With Various Advanced Solid Tumors
  NCT06943521 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
  NCT05877599 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Los Angeles, Newport Beach, Santa Monica
• A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
  NCT05208762 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Irvine, Orange, Sacramento
• A Study of PHN-012 in Patients With Advanced Solid Tumors
  NCT07127874 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, San Diego
• A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
  NCT06914128 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Los Angeles, San Francisco, Stanford
• A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
  NCT07227168 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• A Study of Sigvotatug Vedotin in Advanced Solid Tumors
  NCT04389632 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Anaheim, Fullerton, Los Alamitos, Los Angeles
• A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
  NCT05968326 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Newport Beach, San Francisco, Santa Monica
• A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
  NCT07522073 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Fullerton, La Jolla, Long Beach
• A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
  NCT06179160 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Palo Alto, Santa Monica
• A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
  NCT06440005 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
  NCT05941507 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
  NCT07409272 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Fullerton, Irvine, Los Angeles, Newport Beach
• A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
  NCT06330064 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Whittier
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
  NCT06051695 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, Los Angeles, Stanford
• A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
  NCT07094204 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Santa Monica
• A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
  NCT06989437 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Encinitas, Irvine, La Jolla, Los Angeles
• A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
  NCT07090499 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Irvine, Los Angeles, Santa Monica
• A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
  NCT06760819 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
  NCT06885034 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Alamitos, Los Angeles, Santa Monica, Whittier
• A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
  NCT04503265 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
  NCT04678648 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
  NCT07619313 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
  NCT07094113 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Los Angeles
• ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
  NCT07444541 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• AOH1996 for the Treatment of Refractory Solid Tumors
  NCT05227326 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Long Beach
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
  NCT03175224 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
  NCT04858334 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Arroyo Grande, Berkeley, Burbank, Fremont
• ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
  NCT07505797 · Phase: Not specified · Ages: 18 Years to 94 Years · Sex: Female · California: Sacramento
• AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
  NCT06219941 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Orange, Palo Alto, Santa Rosa
• Access to Genetic Testing in Underserved Patients With Cancer
  NCT06422455 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
  NCT06850623 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Stanford
• Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
  NCT06698458 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 120 Years · Sex: All (male and female) · California: Los Angeles
• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
  NCT07562152 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• BBO-11818 in Adult Subjects With KRAS Mutant Cancer
  NCT06917079 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Sacramento, San Diego, San Francisco
• Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
  NCT04924075 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · California: Los Angeles
• Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
  NCT03260842 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Stanford
• Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
  NCT06651580 · Phase: Not specified · Ages: Up to 17 Years · Sex: All (male and female) · California: Los Angeles, Oakland, Palo Alto
• Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts
  NCT07767227 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Newport Beach
• Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
  NCT07087054 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Newport Beach
• Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
  NCT06790602 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · California: Arroyo Grande, Bakersfield, Burbank, Carmichael
• Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
  NCT05297734 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Fresno, Fruitdale, Fullerton
• Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
  NCT04239573 · Phase: Not specified · Ages: 50 Years to 75 Years · Sex: All (male and female) · California: Burbank, Encinitas, La Jolla, Loma Linda
• Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
  NCT03492151 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Stanford
• DESTINY-PANTUMOUR04
  NCT07124000 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · California: San Diego
• Distance-Based Exercise to Preserve Function and Prevent Disability
  NCT07059884 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Dublin, Fremont, Fresno, Modesto
• EXoPERT EMERALD Clinical Study
  NCT07186296 · Phase: Not specified · Ages: 45 Years and older · Sex: All (male and female) · California: Long Beach, Los Angeles
• Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
  NCT03460769 · Phase: Not specified · Ages: 30 Years to 84 Years · Sex: All (male and female) · California: Los Angeles, Stanford
• ExoLuminate Study for Early Detection of Pancreatic Cancer
  NCT05625529 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
  NCT06539169 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Los Altos
• Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
  NCT07033689 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
  NCT04665947 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento
• Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
  NCT06454383 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
  NCT04119024 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Duarte, Los Angeles, Stanford
• Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
  NCT05746182 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, San Diego, San Francisco
• Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
  NCT01954992 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Whittier
• Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
  NCT06600906 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Increasing Germline Genetic Testing for Patients With Cancer
  NCT07307664 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · California: Los Angeles
• Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
  NCT03257033 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Loma Linda, Sacramento
• Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
  NCT06205849 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla
• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
  NCT06026410 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
  NCT06807437 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, La Jolla, Loma Linda, Los Angeles
• MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
  NCT06586515 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Santa Monica
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
  NCT05059444 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, Newport Beach, Redwood City, Sacramento
• PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
  NCT06673017 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Newport Beach
• Pan-tumor MRD Study
  NCT06605404 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• Pancreatic Cancer Detection Consortium
  NCT06388967 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Monrovia, Newport Beach
• Pancreatic Cancer Early Detection Consortium
  NCT04970056 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · California: Burbank, Duarte, La Jolla, Los Angeles
• Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
  NCT03384238 · Phase: Phase 1, Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · California: Palo Alto